CHICAGO — It was, by all accounts, a pretty slow year at the annual meeting of the American Society of Oncology. But the pace of cancer research is so fast that even during a slow year a lot happens. Here’s our review of some of the most important developments revealed at the largest annual meeting of cancer doctors.

Targeted therapies on top

For a few years, most big cancer meetings have been all about immunotherapy, with the spotlight on big, practice-changing clinical trials showing how the immune system can be directed to kill cancer cells.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy